Imaging Probe Types

Product#: DC-Imaging-Probe-Types
$0.00

Select BIOACT

  • Check below icons

Availability:
Ships in 24 hours

Some of items are currently out of stock. Please submit an inquiry if you would like to check availability or make a purchase

Inquire about the Item  to,   support@diagnocine.com

In Vivo Imaging Probes (Fluorescence)

 

NpFlamma® HGC series
NpFlamma® HGC series is a fluorescent dye incorporated biocompatible and biodegradable chitosan based amphiphilic nanoparticle that enables to selectively detect tumor cells. Chitosan nanoparticles can selectively accumulate in cancer tissues due to high permeability for loose new blood vessels around cancer tissues and retention effect. The polymeric nanoparticles form self-aggregates size of several hundred nanometers in the aqueous system accumulate only in vicinity of cancer tissues. Chitosan particles display low toxicity along with absence of noticeable side effect in vivo, yet they exhibit a long half-life, high stability and aqueous solubility. Thus, NpFlamma® HGC series is an ideal fluorescence agent for in vivo imaging of angiography and tumor progression. In conjunction with NIR dyes, the series allows to observe non-invasive images of cancer metastases and to contrast blood vessel. The hydrophobic nature of NpFlamma® HGC series can embed hydrophobic materials, thus they can be utilized as a selective carrier for hydrophobic cancer drugs such as doxorubicin and paclitaxel, etc. In addition, carboxylic acids on the surface of NpFlamma® HGC series can bind to a variety of biomolecules via amide or ester linkages enabling to utilize them in multi-purposes.

NpFlamma® MMP series
Matrix metalloproteinases (MMPs) are a group of calcium-dependent, zinc-containing endopeptidases that that in concert are responsible for the degradation of most extracellular matrix (ECM) proteins during organogenesis, growth and normal tissue turnover. Humans have 23 MMPs family, and the expression and activity of MMPs in adult tissues is normally quite low, but increases significantly in various pathological conditions that may lead into unwanted tissue destruction, tumor growth and metastasis, inflammatory diseases, etc. Cancer cells secrete VEGF and FGF in order to induce angiogenesis in vascular endothelial cells, but cannot reach to vascular endothelial cells as being caught in ECM. Although MMPs are connected with cancer cells survival and expansion, only very small amount of MMPs are synthetized by cancer cell. However, the cancer cells induce inflammatory cells to secrete MMPs for assisting the delivery of VEGF secreted by cancer cells and make peripheral space for angiogenesis. The connection between MMPs and apoptosis, cell migration and angiogenesis enables to utilizing MMPs as tumor markers. An increased expression and activity of MMPs in both tissues and blood of patients with various types of cancer is observed.

Annexin V Flamma® series
Annexin V Flamma® series is a rapid and selective probe for labeling of externalized PS, an indicator of intermediate stages of apoptosis. Flamma® dyes display strong absorption, high fluorescence quantum yield and high photostability, and they maintain good fluorescence activity and stability after conjugation to biomolecules, allowing the detection of low-abundance biological structures with great sensitivity. Annexin V Flamma® conjugates can be utilized in fluorescent imaging as well as for flow cytometry of apoptotic cells, and they might be used in combination with other dyes such as propidium iodide (PI) in order to accurately analyze mixed populations of apoptotic and other cells. Annexin V Flamma® probes available as stand-alone reagent or easy-to-us kits.

ApoFlamma® series
ApoFlamma® H series made up of a covalent-connection of CQRPPR hexapeptide (ApoPep) with corresponding fluorophore. ApoPep strongly binds to apoptotic and necrotic cells but weakly binds to live cells. The receptor for ApoPep was histone H1 that exposed on the surface of apoptotic cells. In necrotic cells, ApoPep entered the cells and bound to histone H1. The monitoring of tumor apoptosis in response to chemotherapy can be easily realized with optical imaging technique utilizing ApoFlamma® H series. We recommend ApoFlamma® H series as versatile fluorescent probes for in vitro and in vivo imaging of apoptosis with targeting for histone H1.

AngioFlamma® series
Integrins are heterodimeric transmembrane receptors for cell adhesion to extracellular matrix (ECM) proteins and play important roles in certain cell-cell adhesions. In addition, they make transmembrane connections to the cytoskeleton and activate many intracellular signaling pathways. Because of their role in tumor angiogenesis and progression, integrins have become important diagnostic and therapeutic targets. To date 24 distinct integrins are known, and among them, integrin αvβ3 is known to strongly involve in the regulation of angiogenesis. The αvβ3 is generally expressed in low levels on the epithelial cells and mature endothelial cells, but it is highly expressed in many solid tumors. The αvβ3 levels correlate well with the potential for tumor metastasis and aggressiveness, which make it an important biological target for development of antiangiogenic drugs and molecular imaging probes for early tumor diagnosis.
 

NpFlamma® HGC Series

 
20190319110301.png 20190319110311.png 201903191103210.png 201903191103210.png 201903191103210.png  
648 675 749  774  HGC IGC  
 
Quick link (Cat.#) Series Ex * (nm) Em* (nm) Common
filter set
Excitation
source
PNC1201 NpFlamma® HGC 648 648 675 Cy 5 594, 633 nm
PNC1401 NpFlamma® HGC 675 675 698 Cy 5.5 633, 680 nm
PNC1301 NpFlamma® HGC 749 750 782 Cy 7 680 nm
PNC1601 NpFlamma® HGC 774 777 802 Cy 7.5 785 nm
PNC1501 NpFlamma® HGC ICG 785 821 Cy 7.5 785 nm

NpFlamma® MMP Series

 
20190319110352.png 201903191103021.png 201903191103131.png 201903191103131.png 201903191103131.png 20190319110352.png
MMP-2,9 648 MMP-2,9 675 MMP-2,9 749 MMP-2,9 774 MMP-2,9 ICG MMP-3,7 648
201903191103021.png 201903191103131.png 201903191103131.png 201903191103131.png 20190319110352.png 201903191103021.png
MMP-3,7 675 MMP-3,7 749 MMP-3,7 774 MMP-3,7 ICG MMP-13 648 MMP-13 675
201903191103131.png 201903191103131.png 201903191103131.png      
MMP-13 749 MMP-13 774 MMP-13 ICG      
 
Quick link (Cat.#) Series Ex * (nm) Em* (nm) Common
filter set
Excitation
source
PNM0103 NpFlamma® MMP-2,9 648 648 670 Cy 5 594, 633 nm
PNM0104 NpFlamma® MMP-2,9 675 683 694 Cy 5.5 633, 680 nm
PNM0105 NpFlamma® MMP-2,9 749 760 778 Cy 7 785 nm
PNM0106 NpFlamma® MMP-2,9 774 793 810 Cy 7.5 785 nm
PNM0101 NpFlamma® MMP-2,9 ICG 798 835 Cy 7.5 785 nm
PNM0203 NpFlamma® MMP-3,7 648 648 670 Cy 5 594, 633 nm
PNM0204 NpFlamma® MMP-3,7 675 683 694 Cy 5.5 633, 680 nm
PNM0205 NpFlamma® MMP-3,7 749 760 778 Cy 7 785 nm
PNM0206 NpFlamma® MMP-3,7 774 793 810 Cy 7.5 785 nm
PNM0201 NpFlamma® MMP-3,7 ICG 798 835 Cy 7.5 785 nm
PNM0303 NpFlamma® MMP-13 648 648 670 Cy 5 594, 633 nm
PNM0304 NpFlamma® MMP-13 675 683 694 Cy 5.5 633, 680 nm
PNM0305 NpFlamma® MMP-13 749 760 778 Cy 7 785 nm
PNM0306 NpFlamma® MMP-13 774 793 810 Cy 7.5 785 nm
PNM0301 NpFlamma® MMP-13 ICG 798 835 Cy 7.5 785 nm

Annexin V Flamma® Series

 
201903191003360.png 20190319100345.png 201903191003120.png 201903191003120.png 201903191003120.png  
648 675 749 774 V-ICG  
 
Quick link (Cat.#) Series λEx (nm) λEm (nm)
XAP1102 Annexin V-FITC Apoptosis detection kit 492 519
XAP1201 Annexin V-Flamma® 488 Apoptosis detection kit 549 564
XAP1301 Annexin V-Flamma® 552 Apoptosis detection kit 648 672
XAP1801 Annexin V-TAMRA Apoptosis detection kit 648 672
XAP2102 Annexin V-FITC 492 519
XAP2202 Annexin V-Flamma® 488 495 519
XAP2302 Annexin V-Flamma® 552 550 565
XAP2802 Annexin V-TAMRA 543 575
XAP2402 Annexin V-Flamma® 648 648 663
XAP2022 Annexin V-Flamma® 675 675 691
XAP2032 Annexin V-Flamma® 749 749 774
XAP2042 Annexin V-Flamma® 774 774 806
XAP2052 Annexin V-ICG 785 821

AngioFlamma® Series

20190319110318.png 20190319110327.png 201903191103350.png 201903191103350.png 201903191103350.png  
648 675 749 774 ICG
 
Quick link (Cat.#) Series λEx (nm) λEm (nm) Common filter set Excitation source Size
ARW1025 AngioFlamma® FAM 492 519 FITC 488 nm 0.5mg, 1mg, 5mg
ARW1011 AngioFlamma® 552 550 565 TRITC 488, 532 nm 0.5mg, 1mg, 5mg
ARR1001 AngioFlamma® TAMRA 543 575 TRITC 488, 532 nm 0.5mg, 1mg, 5mg
ARW1415 AngioFlamma® 581 581 596 TRITC 488, 532 nm 0.5mg, 1mg, 5mg
ARW1215 AngioFlamma® 648 648 663 Cy®5 594, 633 nm 0.5mg, 1mg, 5mg
ARW1501 AngioFlamma® 675 675 691 Cy®5.5 633, 680 nm 0.5mg, 1mg, 5mg
ARW1301 AngioFlamma® 749 749 774 Cy®7 680 nm 0.5mg, 1mg, 5mg
ARW1601 AngioFlamma® 774 774 806 Cy®7.5 785 nm 0.5mg, 1mg, 5mg
ARO1601 AngioFlamma® ICG 785 821 Cy®7.5 785 nm 0.5mg, 1mg, 5mg

ApoFlamma® Series

Diagnocine-F1.png Diagnocine-F1.png Diagnocine-F1.png Diagnocine-F1.png Diagnocine-F1.png  
648 675 749 774 ICG  
 
Quick link (Cat.#) Series Ex * (nm) Em* (nm)
AHW1215 ApoFlamma® H 648 648 663
AHW1501 ApoFlamma® H 675 675 691
AHW1301 ApoFlamma® H 749 749 774
AHW1601 ApoFlamma® H 774 774 806
AHO1601 ApoFlamma® H ICG 785 812
 

 logo_Bioacts.png

Satisfaction
Quality Rating
Value Rating
Style Rating
X